Histidine decarboxylase inhibitors: a novel therapeutic option for the treatment of leydigioma.
Abiuso AMB, Varela ML, Raices T, Irusta G, Lazzati JM, Besio Moreno M, Cavallotti A, Belgorosky A, Pignataro OP, Berensztein E, Mondillo C.
Abiuso AMB, et al. Among authors: mondillo c.
J Endocrinol. 2022 Oct 3;255(3):103-116. doi: 10.1530/JOE-21-0419. Print 2022 Dec 1.
J Endocrinol. 2022.
PMID: 36069766